Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

Reverse genetics for the control of avian influenza.

Neumann G, Hatta M, Kawaoka Y.

Avian Dis. 2003;47(3 Suppl):882-7.

PMID:
14575081
2.

Confronting the avian influenza threat: vaccine development for a potential pandemic.

Stephenson I, Nicholson KG, Wood JM, Zambon MC, Katz JM.

Lancet Infect Dis. 2004 Aug;4(8):499-509. Review.

PMID:
15288823
3.

Generation and evaluation of an H9N1 influenza vaccine derived by reverse genetics that allows utilization of a DIVA strategy for control of H9N2 avian influenza.

Wu R, Chen Q, Zheng L, Chen J, Sui Z, Guan Y, Chen Z.

Arch Virol. 2009;154(8):1203-10. doi: 10.1007/s00705-009-0425-6. Epub 2009 Jun 19.

PMID:
19543688
6.

Recent developments in avian influenza research: epidemiology and immunoprophylaxis.

Tollis M, Di Trani L.

Vet J. 2002 Nov;164(3):202-15. Review.

PMID:
12505393
7.

[Round table discussion on highly pathogenic H5N1 avian influenza].

Nagai Y, Otsuki K, Abe N, Kawaoka Y, Kida H, Kurata T, Sata T, Tashiro M, Yamaguchi N, Yoshikura H.

Uirusu. 2004 Jun;54(1):123-41. Japanese. No abstract available.

PMID:
15449912
8.

[Avian influenza: eradication from commercial poultry is still not in sight].

Landman WJ, Schrier CC.

Tijdschr Diergeneeskd. 2004 Dec 1;129(23):782-96. Review. Dutch.

PMID:
15624878
9.

Responsiveness to a pandemic alert: use of reverse genetics for rapid development of influenza vaccines.

Webby RJ, Perez DR, Coleman JS, Guan Y, Knight JH, Govorkova EA, McClain-Moss LR, Peiris JS, Rehg JE, Tuomanen EI, Webster RG.

Lancet. 2004 Apr 3;363(9415):1099-103.

PMID:
15064027
10.

[Influenza, an existing public health problem].

García-García J, Ramos C.

Salud Publica Mex. 2006 May-Jun;48(3):244-67. Review. Spanish.

11.

Efficacy of vaccines in chickens against highly pathogenic Hong Kong H5N1 avian influenza.

Swayne DE, Beck JR, Perdue ML, Beard CW.

Avian Dis. 2001 Apr-Jun;45(2):355-65.

PMID:
11417815
12.

A gene-based avian influenza vaccine in poultry.

Rao SS, Styles D, Kong W, Andrews C, Gorres JP, Nabel GJ.

Poult Sci. 2009 Apr;88(4):860-6. doi: 10.3382/ps.2008-00360.

PMID:
19276436
13.

Generation of an attenuated H5N1 avian influenza virus vaccine with all eight genes from avian viruses.

Shi H, Liu XF, Zhang X, Chen S, Sun L, Lu J.

Vaccine. 2007 Oct 16;25(42):7379-84. Epub 2007 Aug 24.

PMID:
17870216
14.

Influenza: lessons from past pandemics, warnings from current incidents.

Horimoto T, Kawaoka Y.

Nat Rev Microbiol. 2005 Aug;3(8):591-600. Review.

PMID:
16064053
15.

Development of live attenuated influenza vaccines against pandemic influenza strains.

Coelingh KL, Luke CJ, Jin H, Talaat KR.

Expert Rev Vaccines. 2014 Jul;13(7):855-71. doi: 10.1586/14760584.2014.922417. Epub 2014 May 28. Review.

PMID:
24867587
16.

The avian-origin PB1 gene segment facilitated replication and transmissibility of the H3N2/1968 pandemic influenza virus.

Wendel I, Rubbenstroth D, Doedt J, Kochs G, Wilhelm J, Staeheli P, Klenk HD, Matrosovich M.

J Virol. 2015 Apr;89(8):4170-9. doi: 10.1128/JVI.03194-14. Epub 2015 Jan 28.

17.

Host range restriction and pathogenicity in the context of influenza pandemic.

Neumann G, Kawaoka Y.

Emerg Infect Dis. 2006 Jun;12(6):881-6. Review.

18.

Are we ready for pandemic influenza H5N1?

Stephenson I.

Expert Rev Vaccines. 2005 Apr;4(2):151-5. Review.

PMID:
15889987
19.

The continued pandemic threat posed by avian influenza viruses in Hong Kong.

Hatta M, Kawaoka Y.

Trends Microbiol. 2002 Jul;10(7):340-4. Review.

PMID:
12110213
20.

Current status and future needs in diagnostics and vaccines for high pathogenicity avian influenza.

Swayne DE, Spackman E.

Dev Biol (Basel). 2013;135:79-94. doi: 10.1159/000325276. Epub 2013 May 14.

PMID:
23689886

Supplemental Content

Support Center